The efficiency of dopamine upon the haemodynamic status of patients who underwent open heart surgery was assessed by a systematic evaluation in the postoperative intensive care unit of the Clinique Chirurgicale des Maladies Cardiaques.
Material and Methods Hwmodynamic parameters: In all patients, systemic, left atrial and pulmonary artery pressures, cardiac rhythm and frequency, cutaneous temperature, and urinary output were monitored. Cardiac output was measured by a thermodilution method using a probe placed in the pulmonary artery through the right atrium. Pulmonary and systemic resistances were calculated. Protocol: The study began one or two hours after the patient entered the recovery room when restoration of the blood volume was completed and hamodynamic parameters remained stable. Each successive dosage of 5, 10, 15 ig/kg per min dopamine was studied during 90 minutes and hmmodynamic parameters measured 3 times (every 30 minutes). To prevent interference of one study with another, patients were left free of dopamin between each study. Results: For each patient, the mean value of measurements performed every 30 minutes was calculated for each dosage. The mean of parameter values during perfusion of dopamine was then calculated for the 15 patients and for each dosage and compared to values at rest. Their variations were statistically analysed. Patients: The experiment was made in 15 patients (11 males, 4 females) with adequate postoperative hmmodynamic status. The average age was 48.2 years with a range of 15 to 66 years. Four had venous aorto-coronary by-pass, 4 had a closure for an atrio-septal defect, 7 had valve replacements; 5 aortic, one mitral and one combined aortic and mitral valves.
Results
Adverse reactions: Patients did not complain of any pain or discomfort during the administration of the drug but they had a low level of consciousness and complete ventilatory support. With 5 gik/kg per min dopamine two patients suffered cardiac arrhythmias (Table 1) : one of them had sinus tachycardia after 30 minutes which disappeared in 5 minutes after the perfusion had been stopped. This patient was not excluded from the protocol. The other patient had a burst of premature ventricular beats and a high blood pressure level after 60 minutes; perfusion of dopamine was therefore stopped. It was stopped at 60 minutes in 2 other patients because there was a break in the intrapulmonary probe used for cardiac output measurements.
Perfusion of 10 jLg/kg per min dopamine was carried out in 12 patients: 5 suffered cardiac arrhythmias. Dopamine perfusion had to be stopped in 3 patients for sinus tachycardia after 60 minutes of perfusion. Perfusion of dopamine had to be stopped in 2 patients at 30 minutes because of a burst of premature ventricular beats; and in 2 patients because of impairment of the probe used for cardiac output measurements.
Perfusion of 15 jg/kg per min was carried out in 8 Patients: 2 suffered arrhythmias. There was sinus tachycardia in one, and premature ventricular beats in the other one; the administration of dopamine was interrupted in these 2 patients as soon as rhythm disturbances appeared. No significant difference between parameter variations were observed with either 5, 10 or 15 jg/kg per min dopamine, urinary output excepted: this increased slightly more with 15 pg/kg per min than with 5 or 10 jg/kg per min dopamine.
Discussion
Study of the effects of dopamine upon haemodynamic parameters of 15 patients who underwent open heart surgery confirms the results of other clinical or experimental studies. There were no significant variations of the systemic or pulmonary arterial or left atrial pressures in patients without cardiac arrhythmias, whatever the doses of dopamine used. Dopamine increased urinary output but this was statistically significant only with a concentration of 15 jg/kg per min. Urinary sodium output is also increased, according to the experimental work of Goldberg in animals.
The most important and significant variations were the increase of the cardiac index and frequency. Before dopamine administration, the increase of the cardiac index was proportionally more important in patients whose index was below 3 1/min/m2 than in patients whose index was above this value (Table 3) .
It seems that, during the postoperative period, a cardiac index below 3 l/min/m2 should not be considered normal even if there is not a low cardiac output syndrome. Dopamine should probably be given to these patients to assure better hmemodynamic conditions and prevent the conset of cardiac complications. Arrhythmias have been the only adverse reaction of dopamine observed; 3 of the 15 patients had to be excluded from the protocol for this reason; in contrast, there was no postoperative low cardiac output syndrome (cardiac index below 2 1/min/m2 urinary output below 100 ml/hour, systolic systemic pressure below 100 mmHg and mean left atrial pressure above 20 mmHg).
Conclusion
Dopamine was found to be very effective in patients who underwent open heart surgery. With 5, 10 and 15 jig/kg per min we have observed an increase of cardiac index and urinary output and a decrease of peripheral systemic resistance; there was an increase of heart rate, which becomes an adverse reaction when it passed 150 beats per minute or when premature ventricular beats appeared. These difficulties were never responsible for cardiac function impairment and disappeared some minutes after dopamine administration had been stopped. Dopamine must be used cautiously and its effects have to be monitored by pulmonary and systemic arterial pressures, and cardiac output. The rate of infusion of the drug must be controlled by a system which permits an exact knowledge of the dose infused.
DISCUSSION
Professor Goldberg (Chairman): You mentioned the arrhythmias that these patients had. Were these with the highest doses, or with the lower doses ?
Dr Chauve: Arrhythmias were not observed with doses of 5 jIg/kg per min, but they did occur in some patients with 10 or 15 jg/kg per min. Even so, they did not seem to be dose-related.
Professor Goldberg: This is one of the first papers in which we talk much about adverse effects. I wonder whether anyone else would like to talk about this. We have all seen arrhythmias with the use of dopamine; I certainly have. There are three ways that I have handled this problem. One is to stop the infusion completely, the next is to decrease the infusion rate, and the third is to add an antiarrhythmic drug, as Dr Miller did. I just wonder whether anyone would like to make any comments ? You stopped the drug completely?
Dr Chauve: Yes, we stopped the drug immediately and completely, because the majority of our patients had no heart failure so they did not really need dopamine. This was purely a systematic study of the hlmodynamic effects of the drug after open-heart surgery. The arrhythmias disappeared as soon as the dopamine was stopped.
Dr D J Boullin (Oxford): We have infused dopamine into baboons for another reason than those described so far, and that is for the relief of cerebral arterial spasm. This is pre-empting what I am going to say in the next communication really, but I am not going to talk about systemic administration. When we have given dopaminie systemically at 10 to 60 jg/kg per min we have seen the toxic effects which have been described at length today, and our observations, I think, agree with the clinical data.
Dr J Zaroslinski (Chicago): With regard to the incidence of side-effects, our calculations from the multi-clinic data indicate that the total incidence of side-effects with dopamine is somewhere between 8 and 9%. The incidence of serious sideeffects which required discontinuance of the drug was approximately 2.1 %. A similar number(3.4 %) of patients had side-effects which were eliminated by reduction in dosage; thus, administration of the drug was continued.
Dr Thompson: As I mentioned earlier, we observed a lower incidence of side reactions in patients during dopamine than during isoprenaline or noradrenaline, but many patients were referred for dopamine therapy because of their intolerance to these other catecholamines. I believe it is important to recall that the dosage requirement for dopamine varies enormously, probably determined by the underlying degree of endogenous catecholamine release, the extent of acidosis, &c. For any given patient, increasing dopamine beyond the dose required for the desired haemodynamic effect is inappropriate and likely to cause side reactions. For the patient group as a whole, however, we did not find side reactions any more frequently in those patients who required 200+ ig/kg per min than in those who required only 2 rg/kg per min when the appropriate dose was given. Now in your studies I believe I heard you say that those patients who experienced tachyarrhythmias also had hypertensive reactions, with systolic arterial pressures greater than 200 mm Hg. I would think that a pressor response of that magnitude would indicate excessive dopamine doses for that patient whether they were caused by a dose of 2 1ig/kg per min or 2000 jg/kg per min. Again I must emphasize that in refractory patients to whom we gave gradually increasing doses while monitoring their hmmodynamic responses, we did not observe any more tachyarrhythmias or other side reactions at very high doses (200 + ,ug/kg per min) than we produced in responsive patients with dopamine doses of 5 to 20 jIg/kg per min. It is not the absolute dose that is important but the dose relative to the response of the patienti.e. on the dose response curve you must titrate the dose according to response.
Dr Chauve: It is not yet possible to compare the incidence of arrhythmias in the group of patients with low cardiac output syndrome and in the group with so-called good hmmodynamic status because the numbers are too small, but I would mention that arrhythmias have not been observed in the group With low cardiac output even when doses of 15 jg/kg per min have been used.
Dr A Miller (Chicago): I am a little concerned about Dr Thompson's position which, if you simplify it, says that the sicker the patients and the more they need the drug, the less likely they are to get tachyarrhythmias. That position bothers me. I think that the critical thing is the host. The first thing you have to do is look at the host. A patient postoperatively after an effective cardiac operation is in a totally different position from a patient in cardiogenic shock, or a patient in congestive heart failurewith all due deference to Dr Dollery. I think it is conceivable, just as with digitalis there are times when ventricular ectopic impulse formation decreases, that ventricular prematares decrease with the use of dopamine. You will recall that in one of the patients I presented that ventricular ectopic beat formation did decrease. These were very sick patients, and in two of them there was an increase in ventricular ectopic impulse formation.
So I would really like to support Dr Goldberg's position, namely that if you need the drug and have to continue it, and if it makes sense to continue it, then you must treat these ventricular ectopic impulses as necessary and appropriately.
Professor Goldberg: I did not say that, I was quoting you, but perhaps it is all right. I am not taking any position on this.
Professor J B Briickner (West Berlin): I would like to ask a question about another complication which is, I think, quite unusual. In some of our patients who received larger doses of dopamine for several hours, we have seen degrees of hair loss on dependent parts of the body after they have survived the treatment successfully. Have any of the speakers seen similar things with their patients ? Dr Chauve: I do not know exactly if the hair was intact after the surgical procedure, ask the neurosurgeons; but I can tell you that we did not observe any gross change of the hair in our patients.
